ANUH PHARMA
Back to Balance Sheet
|
ANUH PHARMA Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹25 Cr | ₹20 Cr | ₹29 Cr | ₹33 Cr | ₹23 Cr |
What is the latest Contingent Liabilities ratio of ANUH PHARMA ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹25 Cr |
| Mar2024 | ₹20 Cr |
| Mar2023 | ₹29 Cr |
| Mar2022 | ₹33 Cr |
| Mar2021 | ₹23 Cr |
How is Contingent Liabilities of ANUH PHARMA Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹25 Cr | 24.50 | |
| Mar2024 | ₹20 Cr | -30.61 | |
| Mar2023 | ₹29 Cr | -11.19 | |
| Mar2022 | ₹33 Cr | 40.76 | |
| Mar2021 | ₹23 Cr | - | |
Compare Contingent Liabilities of peers of ANUH PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ANUH PHARMA | ₹803.2 Cr | -3.4% | 1.2% | -2.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,735.0 Cr | -0.6% | 10.3% | 4.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,312.0 Cr | 1.4% | 11% | 11.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,369.0 Cr | -1.5% | 3.3% | 37.6% | Stock Analytics | |
| CIPLA | ₹107,205.0 Cr | -2.6% | 7.9% | -13.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,592.0 Cr | -3.2% | 2.7% | 10.6% | Stock Analytics | |
ANUH PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ANUH PHARMA | -3.4% |
1.2% |
-2.2% |
| SENSEX | -4.3% |
-2.6% |
-7.6% |
You may also like the below Video Courses